Medication-Assisted Treatment Opioid Addiction Hawaii: What Families Need to Know

By | July 24th, 2026

When opioid use affects someone you love, choosing the next step can feel urgent and overwhelming. In Hawaii, drug poisonings have surpassed motor vehicle crashes as the leading mechanism of injury death. Pharmaceutical opiates are involved in at least 41% of fatal drug poisonings. That comes from the Hawaii Department of Health.

MAT is not a moral failure or a shortcut, and it is not a promise of a quick cure. It is one part of whole-person, trauma-informed care that can reduce the burden of cravings and withdrawal so counseling becomes more manageable. Understanding how each medication works, and how outpatient support fits around it, can make the process feel less mysterious and more human.

Medication-assisted Treatment Opioid Addiction Hawaii: What Is Medication-Assisted Treatment for Opioid Addiction?

MAT is an evidence-based approach that uses medication to stabilize brain chemistry while counseling addresses the underlying drivers of addiction. Rather than treating opioid use disorder as a failure of willpower, medication-assisted treatment combines FDA-approved medication with counseling and behavioral therapy. This whole-person approach can reduce the physical disruption of withdrawal and cravings, giving a person more room to participate in care and make steady decisions about recovery.

The Substance Abuse and Mental Health Services Administration (SAMHSA) identifies methadone, buprenorphine, and naltrexone as the three FDA-approved medications used to treat opioid use disorder. SAMHSA also emphasizes that medication is paired with the services and support that help sustain recovery. Medication is one tool in a broader healing journey, not a replacement for emotional support, trauma-informed care, or treatment for co-occurring mental health concerns.

Buprenorphine: A partial opioid agonist

Buprenorphine is a partial opioid agonist. It binds to opioid receptors and can reduce cravings and withdrawal symptoms, but its opioid effects are weaker than those of full agonists such as methadone. That distinction can help stabilize the body while reducing some of the intensity associated with opioid use. A qualified provider determines whether buprenorphine is appropriate, when it should begin, and how it fits into the person’s broader treatment plan.

Naltrexone: An opioid antagonist

Naltrexone works differently. It is an opioid antagonist, meaning it binds to and blocks opioid receptors rather than activating them. According to SAMHSA, naltrexone blocks the euphoric and sedative effects of opioids and can reduce or suppress cravings. Because it does not produce opioid effects, it may be considered when a person has completed the required opioid-free period and a provider believes it is clinically appropriate.

Methadone: A full opioid agonist

Methadone is a full opioid agonist that activates opioid receptors in a controlled, medically supervised way. It can help address withdrawal and cravings, while careful dosing and monitoring support safety. The right medication depends on factors such as current opioid use, withdrawal history, other health conditions, treatment access, and personal goals. There is no single medication that is right for every person.

Medication	Type	How It Works	How It Is Given
Buprenorphine	Partial agonist	Binds to opioid receptors, reduces cravings and withdrawal; effects weaker than full agonists	Prescription from qualified provider, sublingual film or tablet
Methadone	Full agonist	Activates opioid receptors in a controlled way to manage withdrawal and cravings	Dispensed daily at opioid treatment program
Naltrexone	Antagonist	Blocks opioid receptors, prevents euphoric effects, reduces cravings	Monthly injection after opioid-free period

Medication alone does not address every reason opioid use began or continued. Counseling and behavioral therapy can help a person work through trauma, stress, relationships, triggers, and practical barriers while medical care supports physical stability. Families can ask a treatment provider how medication, therapy, relapse-prevention planning, and support for co-occurring conditions will work together. For reliable medication information, see SAMHSA’s overview of medications for opioid use disorder.

How MAT Works With Outpatient Counseling in Hawaii

Medication-assisted treatment works best as part of integrated care: medication can ease withdrawal and cravings. While counseling helps a person understand underlying trauma, build coping skills, and stay connected to recovery.

When withdrawal, cravings, or fear of the next use dominate the day, it can be difficult to focus on a counseling conversation. MAT can provide a steadier starting point. A qualified provider may use methadone, buprenorphine, or naltrexone according to a person’s health history, substance use, treatment goals, and current circumstances. The medication is one tool within a larger plan, not a replacement for healing or personal agency.

Stabilization creates room for meaningful therapy

Once urgent physical and emotional distress is addressed, outpatient counseling can become more practical and productive. Sessions may help a person recognize triggers, manage stress, repair relationships, and respond to trauma without returning to opioid use. Behavioral therapy can also address co-occurring mental health concerns, such as anxiety, depression, or PTSD. The pace and focus should remain individualized, because recovery is a process with ups and downs.

Family members often benefit from understanding this connection. Counseling is not simply a conversation added after medication. It is where a person can practice the skills and decisions that support a more stable life between appointments. Learn more about the role of outpatient counseling in the treatment journey.

Why PHP and IOP can support integrated care

Mana Recovery’s graduated outpatient model includes Partial Hospitalization Program (PHP) and Intensive Outpatient Program (IOP) levels. These formats can provide regular structure, clinical support, and behavioral care while allowing appropriate connection to work, family, and community life. A treatment team can coordinate counseling with medication management and adjust the level of support as needs change.

For families comparing care options, a guide to outpatient programs for opioid addiction can help explain what to ask about frequency, clinical coordination, family involvement, and support between sessions. The right plan should meet the whole person, not only the symptoms of opioid use.

Hawaii resources can help families take the next step

Community-based support matters across Hawaii’s islands. Kū Aloha Ola Mau has provided outpatient medication treatment since 1976 and has served more than 14,000 people in Honolulu and Hilo. According to the research for this guide. If you need help locating services or understanding available options, Hawaii CARES can be reached at (808) 832-3100 on Oahu or (800) 753-6879 on the neighbor islands.

These resources do not replace a personalized assessment. They can, however, help you move from uncertainty toward a conversation with a qualified treatment provider.

Common Myths About MAT , And the Facts

Answer: Medication-assisted treatment (MAT) is not a substitute for recovery or a last resort. It is an evidence-based medical approach that can reduce withdrawal and cravings, support stability. And give people more room to participate in counseling and the rest of their healing journey.

Myth: MAT is just replacing one addiction with another

Fact: The medications used in MAT do not all work the same way, and treatment is monitored by qualified providers. Buprenorphine is a partial opioid agonist. It binds to opioid receptors and can reduce cravings and withdrawal, but its effects are weaker than those of full opioid agonists such as heroin. That distinction helps explain why it can support stabilization without producing the same intensity of euphoria associated with misuse of full agonists. SAMHSA identifies buprenorphine as one of three FDA-approved medications used to treat opioid use disorder, alongside methadone and naltrexone.

MAT is also not meant to stand alone as a quick fix. Providers can coordinate medication management with therapy, behavioral support, and care for co-occurring mental health concerns. That whole-person approach matters when trauma, stress, or family strain are part of the picture. If you are comparing care options, this guide to opioid addiction treatment offers additional context.

Myth: You should be able to quit without medication

Fact: Opioid use disorder is a chronic medical condition, not a test of character or willpower. As with conditions such as diabetes or hypertension, medication may be an appropriate part of care. Choosing MAT does not mean someone is taking an easier path. It means the treatment plan is responding to the biology of opioid dependence while counseling addresses behavior, relationships, trauma, and other underlying needs.

Hawaii also uses clinical safeguards to support responsible prescribing. The state’s Prescription Monitoring Program allows prescribers and pharmacists to review Schedule II-IV prescriptions to improve quality of care and help prevent misuse. See the Hawaii Department of Health overview for more information.

Myth: MAT is only for severe cases

Fact: Treatment should be based on an individual’s assessment, goals, medical history, and current needs, not on a stigma-based threshold. SAMHSA’s guidance presents medication treatment as an option across the spectrum of opioid use disorder. A provider can discuss whether buprenorphine, methadone, naltrexone, or another level of support fits the person in front of them.

Access also broadened in 2023 when the federal X-waiver requirement for prescribing buprenorphine ended. Before that change, qualified practitioners faced patient limits. The change removed that special waiver barrier, although clinicians still must follow applicable federal and state prescribing requirements. It was an important step toward making evidence-based care easier to reach, including in communities where geography and provider availability can create additional barriers.

When a loved one repeats one of these myths, a compassionate conversation can begin with a licensed provider rather than an argument. Good care explains both the benefits and limits of MAT, includes the person’s voice, and adjusts as recovery needs change.

The Hawaii Opioid Crisis: Why MAT Matters Now

Answer capsule: Medication-assisted treatment can help Hawaii communities respond to a changing overdose crisis by pairing evidence-based medication with counseling and ongoing support. Including when opioid use overlaps with stimulant use or other substances.

Hawaii’s need is urgent. CDC SUDORS data show overdose deaths increased from 252 in 2021 to 360 in 2024, a 42.9% rise. Meth-involved deaths also climbed from 214 to 275, nearly 50%. Fentanyl-only deaths declined from 43 to 28 during that period, but that shift does not mean the danger has eased. Fentanyl increasingly appears alongside stimulants and other substances, creating polysubstance risks that can be difficult for families and providers to recognize.

A changing crisis requires flexible care

Drug poisonings have surpassed motor vehicle crashes as the leading cause of injury death in Hawaii. The state’s Department of Health also reports that pharmaceutical opiates are involved in at least 41% of fatal drug poisonings. These patterns show why prevention, early intervention, medication access, and whole-person treatment must work together. Providers can use tools such as Hawaii’s Prescription Monitoring Program to monitor Schedule II-IV prescriptions and support safer care.

MAT is not limited to one substance profile or one point in a person’s healing journey. A qualified provider can assess opioid use, stimulant use, mental health needs, withdrawal risk, medical history, and family circumstances before recommending a treatment plan. That assessment matters across the islands, where transportation, provider availability, and continuity of care can affect access.

Turning settlement funds into lasting access

Hawaii is expected to receive approximately $150 million in opioid settlement funds through 2038 for statewide abatement, remediation, and recovery initiatives, according to the Hawaii Opioid Settlement Project. Those resources create an opportunity to expand community-based treatment, workforce capacity, overdose prevention, and coordinated services rather than relying on short-term responses.

For families seeking help now, exploring addiction treatment in Hawaii can be a practical starting point. Expanding MAT across the islands means making care easier to reach, culturally responsive, and connected to counseling and mental health support. No single service solves the crisis, but timely, integrated care can give more people a stable path into recovery.

Finding MAT Programs in Hawaii: A Practical Guide

Answer capsule: Finding medication-assisted treatment in Hawaii usually starts with a clinical assessment, followed by a medication plan, counseling, and ongoing monitoring that can be adjusted as recovery needs change.

When you contact a program, ask whether it provides all parts of care or coordinates with outside prescribers and pharmacies. The right fit depends on medical history, current opioid use, withdrawal risk, goals, transportation, and whether treatment needs to work around employment or family responsibilities.

Know the three medication options

Federal guidance identifies three FDA-approved medications for opioid use disorder: methadone, buprenorphine, and naltrexone. Methadone is dispensed through opioid treatment programs, often with daily dosing at the beginning of care. Buprenorphine is a partial opioid agonist that can reduce withdrawal symptoms and cravings with weaker effects than full opioid agonists. Naltrexone blocks opioid receptors and is available as a monthly injection for appropriate patients. A qualified provider will discuss the benefits, safety considerations, and practical requirements of each option rather than treating every person the same.

SAMHSA explains how these medications fit into treatment, which also includes counseling and behavioral therapies.

Ask what the first weeks will involve

Most programs begin with an assessment covering substance use, physical health, mental health, medications, and support needs. The provider may then plan induction, monitor withdrawal symptoms and side effects, and schedule follow-up visits. Ongoing care can include medication management, drug screening when clinically appropriate, individual counseling, group counseling, and support for co-occurring concerns.

Access has also become more flexible. Buprenorphine prescribing no longer requires the federal X-waiver that was discontinued in 2023, although prescribers still must meet applicable training and practice requirements.

Check coverage and integrated outpatient care

Med-QUEST covers MAT services in Hawaii, but benefits, provider participation, and referral requirements can vary. You can review addiction treatment in Hawaii and ask a program to verify coverage before the first appointment. If you are unsure where to begin, Hawaii CARES can provide information and referrals at (808) 832-3100 on Oahu or (800) 753-6879 on neighboring islands.

Mana Recovery integrates medication management with PHP and IOP outpatient care, individual and group counseling, and holistic therapies. This whole-person model gives someone space to stabilize while also addressing trauma, mental health, relationships, and daily routines. The recover strong program may be one option to discuss when movement and wellness support are part of the care plan.

When comparing programs, ask who prescribes the medication, how quickly an assessment can occur, how emergencies are handled, and how counseling connects to the medication plan. Clear answers can help your family choose care that is practical, respectful, and sustainable.

Frequently Asked Questions

Is MAT just replacing one addiction with another?

No. MAT combines FDA-approved medication with counseling and behavioral therapies to treat opioid use disorder as a whole. Buprenorphine works as a partial opioid agonist, helping reduce cravings and withdrawal with weaker effects than full agonists. The goal is stabilization and meaningful participation in recovery, not punishment or shame. SAMHSA explains the treatment approach.

Can someone take MAT long-term?

There is no single timeline that fits every person. A qualified provider can review cravings, withdrawal, health needs, support system, and progress in counseling before recommending how treatment should continue. Medication changes should always be planned with the care team rather than made suddenly or alone.

What is the difference between methadone and buprenorphine?

Both can support treatment for opioid use disorder, but they work differently. Buprenorphine is a partial opioid agonist that binds to opioid receptors and can reduce cravings and withdrawal symptoms. While methadone is one of the FDA-approved medications used in MAT. A provider considers the person’s medical history, treatment setting, and goals when discussing options. SAMHSA describes buprenorphine’s effects.

Can someone receive MAT without counseling?

Medication can address physical aspects of opioid use disorder, but the MAT model includes counseling and behavioral therapies. Counseling can help a person work through trauma, stress, relationships, and triggers while medication supports stabilization. Outpatient care may make it possible to receive both forms of support while staying connected to family and daily responsibilities.

Does Med-QUEST cover MAT in Hawaii?

Coverage and authorization can depend on the medication, provider, plan, and level of care. Ask a Hawaii treatment provider or Med-QUEST directly what is covered, whether prior authorization is needed, and which clinics accept your plan. Mana Recovery serves people who rely on public insurance and can help clarify the next step without judgment.

Ready to explore support for your loved one?

MAT can offer a structured starting point while counseling helps your loved one address the emotional and practical parts of recovery. Every healing journey is different, and a compassionate conversation can clarify what outpatient care in Hawaii may look like. To learn more, call Mana Recovery at (808) 736-1527 and speak with our team about combining MAT with outpatient counseling.